TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010
TCL Archive Advisors approve NCI’s revised plan for $104-million proteomics research program. July 8, 2005
TCL Archive NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution November 1, 1974